Painting The Reply of the Zaporozhian Cossacks to Sultan of Turkey by Ilya Yefimovich Repin
This is a double blind randomised phase II study. Patients will be randomised to receive cediranib and saracatanib or cediranib and placebo. Patients will be assessed at the same frequency in both arms and progression will be assessed against the RECIST criteria.
If you require any help, please contact:
Joanna Dunlop
Email: joanna.dunlop@nhs.net
Randomisation service provided by: Sealed Envelope.com
